Veerendra Munugalavadla

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Chronic Lymphocytic Leukemia

Circulating Tumor

Multiple Myeloma

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

British journal of haematology

Therapeutic advances in hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Mark J Roschewski, Manish R Patel, Patrick M Reagan, Nakhle S Saba, Graham P Collins, Hendrick-Tobias Arkenau, Sven de Vos, Barret R B Nuttall, Melih Acar, Kathleen Burke, Rafael D White, Maria Udriste, Shringi Sharma, Brian Dougherty, Daniel Stetson, David F Jenkins, Andrew Mortlock, Alessandra Forcina, Veerendra Munugalavadla, Ian W Flinn
Phase 1 Study of Acalabrutinib Plus Danvatirsen (AZD9150) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Including Circulating Tumor DNA Biomarker Assessment. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Wojciech Jurczak, Nagah Elmusharaf, Christopher Paul Fox, William M Townsend, Amanda G Paulovich, Jeffrey R Whiteaker, Fanny Krantz, Chuan-Chuan Wun, Graeme Parr, Shringi Sharma, Veerendra Munugalavadla, Richa Manwani, Emma Dean, Tahla Munir
Phase I/II results of ceralasertib as monotherapy or in combination with acalabrutinib in high-risk relapsed/refractory chronic lymphocytic leukemia. Therapeutic advances in hematology 14 (2023)
Deepti Gadi, Alec Griffith, Zixu Wang, Svitlana Tyekucheva, Vanessa Rai, Stacey M Fernandes, John-Hanson Machado, Veerendra Munugalavadla, James Lederer, Jennifer R Brown
Idelalisib reduces regulatory T cells and activates T helper 17 cell differentiation in relapsed refractory patients with chronic lymphocytic leukaemia. British journal of haematology 197 (2) (2022)